Indefinite Delivery Contract 75D30126D20717
Award Date 12/31/25
Last Date to Order 2/28/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Sanofi Pasteur Inc. was awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC) on December 31, 2025, with a ceiling value of $337.36 million through February 28, 2027. The contract procures pediatric influenza vaccines for children ages 0-18 through the Vaccines for Children (VFC) program, which provides immunizations to Medicaid-eligible children, uninsured children, American Indian/Alaska Native children, and...
- This Indefinite Delivery Contract (IDC), awarded to Sanofi Pasteur Inc. on December 31, 2024, establishes a multiple-award vehicle through the Centers for Disease Control and Prevention (CDC) for the procurement of pediatric flu vaccines. The contract carries a ceiling value of $163.14 million and extends through February 28, 2026. As a civilian federal contract with no set-aside designation, this IDC enables the CDC to issue task orders for vaccine delivery to support national immunization...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
- The Centers for Disease Control and Prevention awarded Sanofi Pasteur Inc. a multiple-award indefinite delivery contract with a potential value of $67,076,901.90 to procure adult flu vaccines for 2023-2024. No set-aside was used for this award. Under the terms of the contract, the awardee will deliver flu vaccines to the CDC through the period ending February 28, 2024. The solicitation sought to procure adult flu vaccines in support of the CDC's efforts to prevent the spread of influenza. As the...
- Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed to...
- This multiple-award Indefinite Delivery Contract between the Centers for Disease Control and Prevention (CDC) Pittsburgh and Sanofi Pasteur Inc. establishes a vehicle for the procurement of adult vaccines with a ceiling value of $54.7 million. The contract, awarded on July 1, 2025, with an ultimate completion date of June 30, 2026, carries no set-aside designation and operates under the Vaccines major program code. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in...
- This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...
- This Indefinite Delivery Contract (IDC), awarded to Sanofi Pasteur Inc. on December 31, 2024, establishes a multiple-award vehicle for the procurement of pediatric influenza vaccines under the designation "2025-6 PEDIATRIC FLU VACCINES." The contract is funded by the Centers for Disease Control and Prevention (CDC) Atlanta office through its civilian health operations and carries a ceiling value of $70,175,358.50 with a performance period extending through February 28, 2026. As a...
- Sanofi Pasteur Inc. was awarded a multiple-award indefinite delivery contract by the Centers for Disease Control and Prevention (CDC) on July 1, 2024, with a ceiling value of approximately $54.98 million and a performance period extending through June 30, 2025. This civilian contract, which carries no set-aside designation, establishes a vehicle for the CDC's National Center for Immunization and Respiratory Diseases to procure various adult vaccines on an indefinite-quantity basis. The...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022. The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...